DEERFIELD MANAGEMENT COMPANY, L.P.
Q4 2025 13F Holdings
- Locationnew york, NY
- Num holdings
150
- Value ($000)
$7,830,166
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001009258
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
NUVALENT INC | COM | 670703107 | $1.74B | 22 % | 17,248,450 | ||
BROOKDALE SR LIVING INC | NOTE 3.500%10/1 | 112463AF1 | $427.49M | 6 % | 306,885,000 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | $321.24M | 4 % | 9,043,903 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | $266.25M | 3 % | 903,351 | ||
CENTENE CORP DEL | COM | 15135B101 | $265.34M | 3 % | 6,447,998 | ||
VIATRIS INC | COM | 92556V106 | $251.57M | 3 % | 20,206,170 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | $230.56M | 3 % | 2,894,613 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | $207.57M | 3 % | 425,993 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | $205.58M | 3 % | 4,059,695 | ||
MIRUM PHARMACEUTICALS INC | NOTE 4.000% 5/0 | 604749AB7 | $180.71M | 2 % | 70,000,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100